Citius Oncology, Inc. (CTOR)
Healthcare
Drug Manufacturers - Specialty & Generic
0.63 $
+5.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Citius Oncology, Inc. (CTOR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -4.0 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q4 22 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.0 | -0.1 | -0.2 | -0.2 | -0.4 | 0.9 | 0.0 | 0.0 | 0.0 | -5.5 | -7.4 | -4.0 | -17 | |
| – | – | – | – | – | – | 0.0 | 0.0 | – | – | 0.6 | 1.7 | – | |
| – | 0.0 | 1.9 | 0.0 | 2.0 | 1.7 | 1.8 | 0.0 | 0.0 | 2.3 | 4.0 | 3.5 | 9.8 | |
| 0.1 | 0.3 | 0.0 | 0.1 | 0.0 | 13 | 4.6 | 5.3 | 3.0 | -3.0 | -6.6 | 18 | 11 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -64 | -0.6 | -0.7 | 25 | 0.0 | -29 | – | – | – | -5.8 | -4.4 | -0.7 | – | |
| 64 | 0.4 | 0.9 | -25 | 0.4 | 28 | 0.0 | 0.0 | – | 15 | 15 | 0.0 | – | |
| – | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 3.9 | 3.4 | -4.7 | 2.6 | |
| 0.0 | -0.1 | -0.2 | -0.2 | -0.4 | 0.9 | 0.0 | 0.0 | 0.0 | -5.5 | -7.4 | -4.0 | -17 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.